08.18.17
QPharma, a provider of compliance and commercial services to the life sciences industry, is expanding its footprint with the opening of a new office in the Somerset area of New Jersey. This centrally located location will enable the company to better serve its growing roster of pharmaceutical, medical device, and biotechnology clients, many of which are headquartered throughout New Jersey’s life sciences corridor.
The new 2,300 square-foot office will be staffed by representatives from the company’s commercial operations and information technology divisions. The company will continue to maintain its headquarters in Morristown, which houses the company’s primary commercial operations, professional services, back-office, and technology groups, and its VAWD-accredited fulfillment center in Cedar Knolls.
“QPharma has enjoyed rapid and consistent business growth in 2017,” said Patrick Den Boer, the company’s president and chief executive officer. “Not only have we outgrown our present facilities, but based on client and industry needs we’re also seeing an increased need for a new, strategically located presence in the Somerset area.”
The company is planning an international expansion, with presences in Europe and Asia, in 2018.
The new 2,300 square-foot office will be staffed by representatives from the company’s commercial operations and information technology divisions. The company will continue to maintain its headquarters in Morristown, which houses the company’s primary commercial operations, professional services, back-office, and technology groups, and its VAWD-accredited fulfillment center in Cedar Knolls.
“QPharma has enjoyed rapid and consistent business growth in 2017,” said Patrick Den Boer, the company’s president and chief executive officer. “Not only have we outgrown our present facilities, but based on client and industry needs we’re also seeing an increased need for a new, strategically located presence in the Somerset area.”
The company is planning an international expansion, with presences in Europe and Asia, in 2018.